Erin Wright
Stock Analyst at Morgan Stanley
(4.67)
# 212
Out of 4,412 analysts
162
Total ratings
67.14%
Success rate
15.58%
Average return
Main Sectors:
36 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVST Envista Holdings | Downgrades: Equal-Weight | $33 → $21 | $20.62 | +1.84% | 5 | Apr 26, 2024 | |
| ALGN Align Technology | Maintains: Overweight | $344 → $360 | $304.82 | +18.10% | 18 | Apr 25, 2024 | |
| MCK McKesson | Maintains: Overweight | $522 → $548 | $536.09 | +2.22% | 4 | Apr 15, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Underweight | $21 → $20 | $18.02 | +10.99% | 4 | Apr 1, 2024 | |
| CI Cigna | Reiterates: Overweight | $382 → $392 | $356.44 | +9.98% | 3 | Mar 4, 2024 | |
| ELAN Elanco Animal Health | Maintains: Overweight | $16 → $17 | $13.57 | +25.28% | 8 | Feb 27, 2024 | |
| BTSG BrightSpring Health Services | Initiates: Overweight | $18 | $10.91 | +64.99% | 1 | Feb 20, 2024 | |
| PDCO Patterson Companies | Maintains: Equal-Weight | $38 → $35 | $26.00 | +34.62% | 5 | Nov 30, 2023 | |
| PETS PetMed Express | Maintains: Underweight | $7 → $6.5 | $4.14 | +57.00% | 10 | Nov 16, 2023 | |
| HSIC Henry Schein | Maintains: Underweight | $69 → $65 | $73.03 | -11.00% | 4 | Nov 14, 2023 | |
| SONX Sonendo | Maintains: Equal-Weight | $5 → $4.6 | $0.09 | +4,762.58% | 6 | Nov 9, 2023 | |
| PAHC Phibro Animal Health | Maintains: Equal-Weight | $17 → $16 | $16.78 | -4.65% | 11 | Nov 9, 2023 | |
| XRAY DENTSPLY SIRONA | Maintains: Overweight | $43 → $39 | $30.69 | +27.08% | 11 | Nov 3, 2023 | |
| CVS CVS Health | Maintains: Overweight | $110 → $100 | $67.45 | +48.26% | 4 | Nov 2, 2023 | |
| CAH Cardinal Health | Maintains: Overweight | $92 → $100 | $102.91 | -2.83% | 5 | Aug 16, 2023 | |
| IDXX IDEXX Laboratories | Maintains: Overweight | $590 → $600 | $505.34 | +18.73% | 9 | Aug 3, 2023 | |
| UNH UnitedHealth Group | Reiterates: Overweight | $587 | $489.03 | +20.03% | 3 | Jul 14, 2023 | |
| ZTS Zoetis | Maintains: Overweight | $264 → $248 | $159.70 | +55.29% | 5 | Nov 15, 2022 | |
| LH Laboratory Corporation of America Holdings | Assumes: Overweight | $300 | $204.17 | +46.94% | 4 | Aug 22, 2022 | |
| DGX Quest Diagnostics | Assumes: Equal-Weight | $142 | $139.50 | +1.79% | 4 | Aug 22, 2022 | |
| AVTR Avantor | Maintains: Outperform | n/a | $24.08 | - | 2 | Jul 30, 2021 | |
| DHR Danaher | Maintains: Outperform | n/a | $246.82 | - | 4 | Jun 18, 2021 | |
| CNTG Centogene | Maintains: Outperform | n/a | $0.46 | - | 1 | Jun 17, 2021 | |
| CRL Charles River Laboratories International | Maintains: Neutral | n/a | $232.10 | - | 3 | May 28, 2021 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | n/a | $7.85 | - | 1 | Mar 3, 2021 | |
| LNTH Lantheus Holdings | Maintains: Neutral | n/a | $67.26 | - | 4 | Feb 26, 2021 | |
| MEDP Medpace Holdings | Maintains: Outperform | n/a | $400.21 | - | 5 | Feb 16, 2021 | |
| CHWY Chewy | Maintains: Outperform | n/a | $15.77 | - | 4 | Jan 13, 2021 | |
| TMO Thermo Fisher | Maintains: Outperform | n/a | $576.89 | - | 4 | Jan 12, 2021 | |
| CERT Certara | Initiates: Neutral | n/a | $17.08 | - | 1 | Jan 5, 2021 | |
| FLGT Fulgent Genetics | Maintains: Neutral | n/a | $20.58 | - | 4 | May 5, 2020 | |
| ICLR ICON PLC | Maintains: Outperform | n/a | $304.14 | - | 1 | Apr 23, 2020 | |
| IQV IQVIA Holdings | Maintains: Outperform | n/a | $235.48 | - | 1 | Apr 2, 2020 | |
| PINC Premier | Maintains: Outperform | n/a | $21.16 | - | 1 | May 9, 2018 | |
| OMI Owens & Minor | Maintains: Underperform | n/a | $25.42 | - | 1 | Nov 20, 2017 | |
| LMT Lockheed Martin | Maintains: Neutral | n/a | $467.55 | - | 1 | Oct 25, 2017 |
Envista Holdings
Apr 26, 2024
Downgrades: Equal-Weight
Price Target: $33 → $21
Current: $20.62
Upside: +1.84%
Align Technology
Apr 25, 2024
Maintains: Overweight
Price Target: $344 → $360
Current: $304.82
Upside: +18.10%
McKesson
Apr 15, 2024
Maintains: Overweight
Price Target: $522 → $548
Current: $536.09
Upside: +2.22%
Walgreens Boots Alliance
Apr 1, 2024
Maintains: Underweight
Price Target: $21 → $20
Current: $18.02
Upside: +10.99%
Cigna
Mar 4, 2024
Reiterates: Overweight
Price Target: $382 → $392
Current: $356.44
Upside: +9.98%
Elanco Animal Health
Feb 27, 2024
Maintains: Overweight
Price Target: $16 → $17
Current: $13.57
Upside: +25.28%
BrightSpring Health Services
Feb 20, 2024
Initiates: Overweight
Price Target: $18
Current: $10.91
Upside: +64.99%
Patterson Companies
Nov 30, 2023
Maintains: Equal-Weight
Price Target: $38 → $35
Current: $26.00
Upside: +34.62%
PetMed Express
Nov 16, 2023
Maintains: Underweight
Price Target: $7 → $6.5
Current: $4.14
Upside: +57.00%
Henry Schein
Nov 14, 2023
Maintains: Underweight
Price Target: $69 → $65
Current: $73.03
Upside: -11.00%
Sonendo
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $5 → $4.6
Current: $0.09
Upside: +4,762.58%
Phibro Animal Health
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $17 → $16
Current: $16.78
Upside: -4.65%
DENTSPLY SIRONA
Nov 3, 2023
Maintains: Overweight
Price Target: $43 → $39
Current: $30.69
Upside: +27.08%
CVS Health
Nov 2, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $67.45
Upside: +48.26%
Cardinal Health
Aug 16, 2023
Maintains: Overweight
Price Target: $92 → $100
Current: $102.91
Upside: -2.83%
IDEXX Laboratories
Aug 3, 2023
Maintains: Overweight
Price Target: $590 → $600
Current: $505.34
Upside: +18.73%
UnitedHealth Group
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $489.03
Upside: +20.03%
Zoetis
Nov 15, 2022
Maintains: Overweight
Price Target: $264 → $248
Current: $159.70
Upside: +55.29%
Laboratory Corporation of America Holdings
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $204.17
Upside: +46.94%
Quest Diagnostics
Aug 22, 2022
Assumes: Equal-Weight
Price Target: $142
Current: $139.50
Upside: +1.79%
Avantor
Jul 30, 2021
Maintains: Outperform
Price Target: n/a
Current: $24.08
Upside: -
Danaher
Jun 18, 2021
Maintains: Outperform
Price Target: n/a
Current: $246.82
Upside: -
Centogene
Jun 17, 2021
Maintains: Outperform
Price Target: n/a
Current: $0.46
Upside: -
Charles River Laboratories International
May 28, 2021
Maintains: Neutral
Price Target: n/a
Current: $232.10
Upside: -
Maravai LifeSciences Holdings
Mar 3, 2021
Maintains: Outperform
Price Target: n/a
Current: $7.85
Upside: -
Lantheus Holdings
Feb 26, 2021
Maintains: Neutral
Price Target: n/a
Current: $67.26
Upside: -
Medpace Holdings
Feb 16, 2021
Maintains: Outperform
Price Target: n/a
Current: $400.21
Upside: -
Chewy
Jan 13, 2021
Maintains: Outperform
Price Target: n/a
Current: $15.77
Upside: -
Thermo Fisher
Jan 12, 2021
Maintains: Outperform
Price Target: n/a
Current: $576.89
Upside: -
Certara
Jan 5, 2021
Initiates: Neutral
Price Target: n/a
Current: $17.08
Upside: -
Fulgent Genetics
May 5, 2020
Maintains: Neutral
Price Target: n/a
Current: $20.58
Upside: -
ICON PLC
Apr 23, 2020
Maintains: Outperform
Price Target: n/a
Current: $304.14
Upside: -
IQVIA Holdings
Apr 2, 2020
Maintains: Outperform
Price Target: n/a
Current: $235.48
Upside: -
Premier
May 9, 2018
Maintains: Outperform
Price Target: n/a
Current: $21.16
Upside: -
Owens & Minor
Nov 20, 2017
Maintains: Underperform
Price Target: n/a
Current: $25.42
Upside: -
Lockheed Martin
Oct 25, 2017
Maintains: Neutral
Price Target: n/a
Current: $467.55
Upside: -